The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives

Thrombosis Research

Volumn 129, Issue 5, 2012, Pages 603-610

  Schlesinger, Martin ^a   Schmitz, Patrick ^a   Zeisig, Reiner ^b   Naggi, Annamaria ^c   Torri, Giangiacomo ^c   Casu, Benito ^c   Bendas, Gerd ^a  

^a UNIVERSITY OF BONN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c Istituto di Ricerche Chimiche e Biochimiche G Ronzoni   (Italy)

Author keywords

biosensor; cell adhesion; heparin; melanoma metastasis; VLA 4

Indexed keywords

ALPHA INTEGRIN; ENOXAPARIN; HEPARIN DERIVATIVE; L SELECTIN; NATALIZUMAB; PADGEM PROTEIN; TINZAPARIN; VERY LATE ACTIVATION ANTIGEN 4;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BIOSENSOR; CELL ADHESION; CONTROLLED STUDY; DRUG PROTEIN BINDING; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG METASTASIS; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETYLATION; ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTICOAGULANTS; CELL ADHESION; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; ENOXAPARIN; FEMALE; GENE KNOCKDOWN TECHNIQUES; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTEGRIN ALPHA4BETA1; MELANOMA; MICE; NEOPLASM METASTASIS; RNA, SMALL INTERFERING; STRUCTURE-ACTIVITY RELATIONSHIP; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84860448186     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.10.023     Document Type: Article

References (41)

1. J. Sleeman, and P.S. Steeg Cancer metastasis as a therapeutic target Eur J Cancer 46 2010 1177 1180
2. P.S. Steeg Tumor metastasis: mechanistic insights and clinical challenges Nat Med 12 2006 895 904
3. R. Schmidmaier, and P. Baumann ANTI-ADHESION evolves to a promising therapeutic concept in oncology Curr Med Chem 15 2008 978 990
4. L. Borsig Antimetastatic activities of heparins and modified heparins. Experimental evidence Thromb Res 125 Suppl 2 2010 66 71
5. H. Läubli, and L. Borsig Selectins promote tumor metastasis Semin Cancer Biol 20 Jun 2010 169 177
6. R.J. Ludwig, B. Boehme, M. Podda, R. Henschler, E. Jager, and C. Tandi Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis Cancer Res 64 2004 2743 2750
7. L. Borsig, R. Wong, J. Feramisco, D.R. Nadeau, N.M. Varki, and A. Varki Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis Proc Natl Acad Sci U S A 98 2001 3352 3357
8. B. Nieswandt, M. Hafner, B. Echtenacher, and D.N. Männel Lysis of tumor cells by natural killer cells in mice is impeded by platelets Cancer Res 59 1999 1295 1300
9. H. Läubli, J.L. Stevenson, A. Varki, N.M. Varki, and L. Borsig L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest Cancer Res 66 2006 1536 1542
10. T. Krause, and G.A. Turner Are selectins involved in metastasis? Clin Exp Metastasis 17 1999 183 192
11. J. Fritzsche, D. Simonis, and G. Bendas Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches Thromb Haemost 100 2008 1166 1175
12. H. Okahara, H. Yagita, K. Miyake, and K. Okumura Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis Cancer Res 54 1994 3233 3236
13. S. Liang, and C. Dong Integrin VLA-4 enhances sialyl-Lewisx/a-negative melanoma adhesion to and extravasation through the endothelium under low flow conditions Am J Physiol Cell Physiol 295 2008 701 707
14. A. Garofalo, R.G. Chirivi, C. Foglieni, R. Pigott, R. Mortarini, and I. Martin-Padura Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases Cancer Res 55 1995 414 419
15. D. Schadendorf, J. Heidel, C. Gawlik, L. Suter, and B.M. Czarnetzki Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels J Natl Cancer Inst 87 1995 366 371
16. U.H. von Andrian, and B. Engelhardt Alpha4 integrins as therapeutic targets in autoimmune disease N Engl J Med 348 2003 68 72
17. M. Schlesinger, D. Simonis, P. Schmitz, J. Fritzsche, and G. Bendas Binding between heparin and the integrin VLA-4 Thromb Haemost 102 2009 816 822
18. E.A. Akl, I. Terrenato, M. Barba, F. Sperati, P. Muti, and H.J. Schünemann Extended perioperative thromboprophylaxis in patients with cancer. A systematic review Thromb Haemost 100 2008 1176 1180
19. E.A. Akl, S. Gunukula, M. Barba, V.E.D. Yosuico, F.F. van Doormaal, and S. Kuipers Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Cochrane Database Syst Rev 1 2011 CD006652
20. C.A. Engman, and L.R. Zacharski Low molecular weight heparins as extended prophylaxis against recurrent thrombosis in cancer patients J Natl Compr Canc Netw 6 2008 637 645
21. N. Hostettler, A. Naggi, G. Torri, R. Ishai-Michaeli, B. Casu, and I. Vlodavsky P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins FASEB J 21 2007 3562 3572
22. S.A. Mousa, and S. Mohamed Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor Thromb Haemost 92 2004 627 633
23. G.C. Jayson, and J.T. Gallagher Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells Br J Cancer 75 1997 9 16
24. I. Vlodavsky, G. Abboud-Jarrous, M. Elkin, A. Naggi, B. Casu, and R. Sasisekharan The impact of heparanese and heparin on cancer metastasis and angiogenesis Pathophysiol Haemost Thromb 35 2006 116 127
25. G. Chalkiadaki, D. Nikitovic, A. Berdiaki, P. Katonis, N.K. Karamanos, and G.N. Tzanakakis Heparin plays a key regulatory role via a p53/FAK-dependent signaling in melanoma cell adhesion and migration IUBMB Life 63 2011 109 119
26. A. Naggi, B. Casu, M. Perez, G. Torri, G. Cassinelli, and S. Penco Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting J Biol Chem 280 2005 12103 12113
27. A. Bisio, D. Vecchietti, L. Citterio, M. Guerrini, R. Raman, and S. Bertini Structural features of low-molecular-weight heparins affecting their affinity to antithrombin Thromb Haemost 102 2009 865 873
28. M. Perpeet, S. Glass, T.M. Gronewold, A. Malave, I. Stoyanov, and M. Tewes SAWSensor System for Marker-Free Molecular Interaction Analysis Anal Lett 39 2006 1747 1757
29. J.E. Lever Active amino acid transport in plasma membrane vesicles from Simian virus 40-transformed mouse fibroblasts. Characteristics of electrochemical Na + gradient-stimulated uptake J Biol Chem 252 1977 1990 1997
30. R.S. Kaplan, and P.L. Pedersen Determination of microgram quantities of protein in the presence of milligram levels of lipid with amido black 10B Anal Biochem 150 1985 97 104
31. A. Varki, N.M. Varki, and L. Borsig Molecular basis of metastasis N Engl J Med 360 2009 1678 1679 1679-80
32. M. Klemke, T. Weschenfelder, M.H. Konstandin, and Y. Samstag High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers J Cell Physiol 212 2007 368 374
33. S. Roy, H. Lai, R. Zouaoui, J. Duffner, H. Zhou, and L.P. Jayaraman Bioactivity screening of partially desulfated low-molecular-weight heparins: a structure/activity relationship study Glycobiology 21 2011 1194 1205
34. D. Simonis, J. Fritzsche, S. Alban, and G. Bendas Kinetic analysis of heparin and glucan sulfates binding to P-selectin and its impact on the general understanding of selectin inhibition Biochemistry 46 2007 6156 6164
35. B.-Z. Qian, and J.W. Pollard Macrophage diversity enhances tumor progression and metastasis Cell 141 2010 39 51
36. L. Wang, J.R. Brown, A. Varki, and J.D. Esko Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins J Clin Invest 110 2002 127 136
37. M. Wei, G. Tai, Y. Gao, N. Li, B. Huang, and Y. Zhou Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions J Biol Chem 279 2004 29202 29210
38. Y. Li, J.-Y. Luo, H.-F. Cui, L. Zheng, and S. Du Study on anti-metastasis of heparin derivatives as ligand antagonist of p-selectin Biomed Pharmacother 64 2010 654 658
39. I. Kenessey, E. Simon, K. Futosi, B. Bereczky, A. Kiss, and F. Erdödi Antimigratory and antimetastatic effect of heparin-derived 4-18 unit oligosaccharides in a preclinical human melanoma metastasis model Thromb Haemost 102 2009 1265 1273
40. A. Koenig, K. Norgard-Sumnicht, R. Linhardt, and A. Varki Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents J Clin Invest 101 1998 877 889
41. M. Schlesinger, A. Naggi, G. Torri, R. Zeisig, M. Alexander, and P. Schmitz Blocking of integrin-mediated human MV3 melanoma cell binding by commercial and modified heparins Int J Clin Pharmacol Ther 48 2010 448 450